in human breast cancer. mRNA expression was evaluated by (q)RT-PCR in a panel of human normal tissues, primary breast cancers and cell lines. A new antibody raised against C78-I97 of the putative BCAR4 protein and used for western blot and immunoprecipitation assays. Furthermore, siRNA-mediated gene silencing was implemented to study the function of BCAR4 and its downstream targets ERBB2/3. acts in an ERBB2/3-dependent manner.-driven tumor cell growth, a clinical relevant observation
Purpose We have previously identified a set of breast cancer antiestrogen resistance (BCAR) genes ca...
Immunohistochemical expression of erbB4 protein was identified in 93% (49 of 53) of ovarian cancers ...
Abstract Background Breast cancer anti-estrogen resistance 4 (BCAR4) is closely associated with colo...
Most breast cancers depend on estrogenic growth stimulation. Functional genetic screenings in in vit...
Background Most breast cancers depend on estrogenic growth stimulation. Functional genetic screening...
Background: Most breast cancers depend on estrogenic growth stimulation. Functional genetic screenin...
textabstractBackground: Most breast cancers depend on estrogenic growth stimulation. Functional gene...
Background Most breast cancers depend on estrogenic growth stimulation. Functional genetic screen-in...
Background:Breast cancer anti-oestrogen resistance 4 (BCAR4) was identified in a search for genes in...
textabstractBackground: High BCAR4 and ERBB2 mRNA levels in primary breast cancer associate with tam...
BACKGROUND: Breast cancer anti-oestrogen resistance 4 (BCAR4) was identified in a search for genes i...
textabstractBreast cancer is one of the most common cancers in women, and it is the second leading c...
textabstractBackground:Breast cancer anti-oestrogen resistance 4 (BCAR4) was identified in a search ...
textabstractINTRODUCTION: Tamoxifen is effective for endocrine treatment of oestrogen receptor-posit...
Background: High BCAR4 and ERBB2 mRNA levels in primary breast cancer associate with tamoxifen resis...
Purpose We have previously identified a set of breast cancer antiestrogen resistance (BCAR) genes ca...
Immunohistochemical expression of erbB4 protein was identified in 93% (49 of 53) of ovarian cancers ...
Abstract Background Breast cancer anti-estrogen resistance 4 (BCAR4) is closely associated with colo...
Most breast cancers depend on estrogenic growth stimulation. Functional genetic screenings in in vit...
Background Most breast cancers depend on estrogenic growth stimulation. Functional genetic screening...
Background: Most breast cancers depend on estrogenic growth stimulation. Functional genetic screenin...
textabstractBackground: Most breast cancers depend on estrogenic growth stimulation. Functional gene...
Background Most breast cancers depend on estrogenic growth stimulation. Functional genetic screen-in...
Background:Breast cancer anti-oestrogen resistance 4 (BCAR4) was identified in a search for genes in...
textabstractBackground: High BCAR4 and ERBB2 mRNA levels in primary breast cancer associate with tam...
BACKGROUND: Breast cancer anti-oestrogen resistance 4 (BCAR4) was identified in a search for genes i...
textabstractBreast cancer is one of the most common cancers in women, and it is the second leading c...
textabstractBackground:Breast cancer anti-oestrogen resistance 4 (BCAR4) was identified in a search ...
textabstractINTRODUCTION: Tamoxifen is effective for endocrine treatment of oestrogen receptor-posit...
Background: High BCAR4 and ERBB2 mRNA levels in primary breast cancer associate with tamoxifen resis...
Purpose We have previously identified a set of breast cancer antiestrogen resistance (BCAR) genes ca...
Immunohistochemical expression of erbB4 protein was identified in 93% (49 of 53) of ovarian cancers ...
Abstract Background Breast cancer anti-estrogen resistance 4 (BCAR4) is closely associated with colo...